On October 27, 2022, Shanghai Feiteng Pharmaceutical Technology Co., Ltd. closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.38 CNY | -6.00% |
|
-6.35% | -50.78% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-50.78% | 911M | |
+55.19% | 815B | |
+46.34% | 654B | |
-6.09% | 354B | |
+21.92% | 337B | |
+19.36% | 247B | |
+3.80% | 229B | |
+14.03% | 219B | |
+10.86% | 171B | |
-2.78% | 159B |
- Stock Market
- Equities
- 300363 Stock
- News Porton Pharma Solutions Ltd.
- Shanghai Feiteng Pharmaceutical Technology Co., Ltd. announced that it has received CNY 60 million in funding from Porton Pharma Solutions Ltd.